Archive Listings
Downloadable Version Notes
2014
Grants Year to Date
This report includes grants totaling approximately $19.7 million from January 1 through December 31, 2014. Grants reflect financial support to US-based, nonprofit organizations that foster increased understanding of scientific, clinical, and healthcare issues and contribute to improving patient care. This includes financial support through contributions, memberships and sponsorships.
2014
Physician Payments
This report includes payments to US physicians related to speaking, advising and consulting and other transfers of value by GSK totaling approximately $36.3 million from January 1 to December 31 2014. For some types of expense, GSK processes allow up to 90 days for reconciliation post payment to finalize costs. Data in this report aligns to data provided by GSK to the General Payments Report submitted to CMS.
2014
Research Payments
This report includes payments made in 2014 for research related activities totaling approximately $179 million. The payee is responsible for management and subsequent distribution of the research payments. Data in this report aligns to data provided by GSK to the Research Payments Report submitted to CMS.
2013
Grants Year to Date
This report includes grants totaling approximately $21.1 million for the full year ending 2013. Grants reflect financial support to US-based, nonprofit organizations that foster increased understanding of scientific, clinical, and healthcare issues and contribute to improving patient care. This includes financial support through contributions, memberships and sponsorships.
2013
Physician Payments
This report includes payments to US physicians related to speaking, advising, and consulting and other transfers of value on behalf of GSK.
2013
Research Payments
This report includes payments totaling about $97 million made in 2013 for research studies started since January 1st, 2010 in which the principal investigator or lead researcher is a US-licensed healthcare professional. The payee is responsible for management and subsequent distribution of the research payment. Payments do not include certain fees paid by GSK to third parties in connection with research studies (such as contract research organization fees, central Institutional Review Board fees,...).